Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Leprosy serology: current status and perspectives].

S Chanteau1, J L Cartel, J Roux

  • 1Institut de Recherches Médicales Louis Malardé, Papeete, Tahiti, Polynésie Française.

Acta Leprologica
|January 1, 1992
PubMed
Summary

Serological tests for leprosy, including antibody and antigen detection, show limited utility for diagnosis and population screening. Current methods lack sufficient specificity and cost-effectiveness for effective leprosy control programs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Long-Acting Ghrelin Analogue PEP-064 Restores Energy Balance in C26 and Lewis Lung Carcinoma-Induced cachexia in Mice.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Neurological manifestations in children with SARS-CoV-2 infection: a French multicentric cohort.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2025
Same author

Species diversity in <i>Pseudocercospora</i>.

Fungal systematics and evolution·2024
Same author

Fungal Planet description sheets: 1383-1435.

Persoonia·2024
Same author

New and Interesting Fungi. 5.

Fungal systematics and evolution·2023
Same author

Fungal Planet description sheets: 1182-1283.

Persoonia·2022

Area of Science:

  • Immunology
  • Microbiology
  • Public Health

Context:

  • Leprosy diagnosis relies on various serological tests detecting antibodies (anti-PGL-1, 35kD, 36kD, LAM) or the PGL-1 antigen.
  • Existing antibody detection tests offer insufficient specificity for definitive leprosy diagnosis and vary in sensitivity between multibacillary and paucibacillary forms.
  • Antigen detection tests are sensitive and specific for multibacillary leprosy but face technical limitations for routine use.

Purpose:

  • To evaluate the diagnostic accuracy and cost-effectiveness of serological tests for leprosy.
  • To assess the utility of antibody and antigen detection assays in leprosy diagnosis and population screening.
  • To determine the correlation between seroprevalence and disease prevalence for M. leprae infection.

Summary:

  • Antibody detection tests exhibit low positive predictive values in low-prevalence populations, rendering them not cost-effective for early diagnosis or high-risk group monitoring.
  • While IgM anti-PGL-1 levels decrease with treatment in multibacillary leprosy, seroprevalence does not correlate with disease prevalence in populations.
  • PGL-1 antigen detection tests are accurate for multibacillary leprosy but impractical for routine application.

Impact:

  • The findings question the current usefulness of serological tests in leprosy control programs.
  • Highlights the need for more accurate, cost-effective, and practical diagnostic tools for leprosy.
  • Suggests that serological screening is not a reliable indicator for M. leprae infection prevalence in the general population.

Related Experiment Videos